Abeona Therapeutics Inc. Common Stock
$5.47
$0.04 (+0.74%)
$5.32Day Range$5.56
Key Statistics
Market Cap
$310.51M
Shares Outstanding
57.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 19, 1980
Round Lot
100
Locale
US
Trading Data
Day Open
$5.42
Day High
$5.56
Day Low
$5.32
Volume
1.93M
VWAP
$5.41
Prev Close
$5.43
Transactions
--
Acc. Volume
--
About Abeona Therapeutics Inc. Common Stock
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
PHARMACEUTICAL PREPARATIONSSIC 2834226 employees6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103646-813-4701IPO Sep 19, 1980US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000318306
- Composite FIGI
- BBG000DT5D52
- Share Class FIGI
- BBG001S8T7K0
- Ticker Root
- ABEO
- SIC Code
- 2834
About Abeona Therapeutics Inc. Common Stock (ABEO) Stock
Abeona Therapeutics Inc. Common Stock (ABEO) closed the 2026-09-15 session at $5.47, up 0.74% versus the previous close (+0.04). The stock opened at $5.42 and traded between $5.32 and $5.56 during that session. Session trading volume was 1.9M shares. The volume-weighted average price (VWAP) is $5.41.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Abeona Therapeutics Inc. Common Stock has a market capitalization of $310.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ABEO is listed on the XNAS exchange. The company employs approximately 226 people. Abeona Therapeutics Inc. Common Stock is headquartered in CLEVELAND, OH. The recorded listing date is 1980-09-19.
On this page you can find market ABEO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.